Pharmacology for renal calculi

Bibliography

• WESHUB LP: Urology: From Antiquity to the 20th Century. Warren H Green (Ed.), St. Louis, MO, USA (1970).
   Google Scholar
• •Accounts history of understanding of stone disease.
   Google Scholar
• WALSH PC: Urinary lithiasis: Etiology, Diagnosis, and Medical Management. In: Urology Vol. III. Menon M, Parulkar B, Drach G (Eds.), WB Saunders, Inc., Philadelphia, USA (1998) Chapter 91.
   Google Scholar
• CURHAN GC, WILLETT WC, RIMM ED et al.: Prospective study of beverage use and risk of kidney stones. Am. J. Epidemic)]. (1996) 143:240–247.
   PubMed Web of Science ®Google Scholar
• ••Demonstrated that prior conventional advice to limitcalcium intake was incorrect.
   Google Scholar
• STRAUS A, COE FL, DEUTSCH L, PARKS JH: Factors thatpredict relapse of calcium nephrolithiasis during treatment: a prospective study. Am. J. Merl. (1982) 72:17–24.
   PubMed Web of Science ®Google Scholar
• SAKLAHEE K, HARVEY JA, PADALINNO PK et al: Thepotential role of self advice on the risk of kidney stone formation. J. Urol. (1993) 150:310–312.
   PubMed Web of Science ®Google Scholar
• CURHAM GC, WILLETT WC, RIMM EB, STUMPFER MJ: Aprospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl. J. Med. (1993) 328:833–838.
   PubMed Web of Science ®Google Scholar
• PAK CYC: Hypercalciuria calcium nephrolithiasis. In:Urolithiasis: A Medical and Surgical Reference. Resnick MI, Pack CYC (Eds.), WB Saunders, Philadelphia, USA (1990)79–88.
   Google Scholar
• COE FL, PAKS JH, BUSHINSKY DA etal.: The pathogenisisand treatment of kidney stones. N Engl. J. Merl. (1992) 327:1141–1152.
   Google Scholar
• •Questions the validity of categorisation of hypercalciuria.
   Google Scholar
• LAMINSKI MA, MEYERS AM, KRUGER M et al.: Hyperox- aluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br. J. Urol. (1991) 61:454–458.
   Google Scholar
• •Demonstrates frequent multiplicity of metabolic abnormali-ties in stone disease.
   Google Scholar
• HAYASHI Y, KAPLAN RA, PAK CYC: Effect of cellulosephosphate therapy on crystallization of calcium oxalate in urine. Metabolism (1978) 24:1273–1278.
   Google Scholar
• YENTA ER, GAGE RJ, COHERING M: The effects of thiazides in idiopathic hypercalciuria. Am. Merl. Sci. (1966) 251:409–416.
   PubMed Web of Science ®Google Scholar
• ••First to describe use of thiazides for hypercalciuria.
   Google Scholar
• YENDT ER, COHANIM M: Prevention of calcium stones with thiazides. Kidney Int. (1978) 13:397–409.
   PubMed Web of Science ®Google Scholar
• PREMINGER GM: Medical management of urinary calculus disease: Part II. Classification of metabolic disorders and selective medical management. AUA Update Series (1995) 14:1–8.
   Google Scholar
• ASSIMOS DG. HOLMES RP, GOODMAN HO: Hypercalci- uria advances in medical therapy. Contemp. Urol. (1997)47.
   Google Scholar
• ETINGER B: Recurrent nephrolithiasis: natural history and effect of phosphate therapy A double-blind controlled study. Am. J. Med. (1976) 61:200–206.
   PubMed Web of Science ®Google Scholar
• •Controlled trial demonstrates efficacy of phosphate therapy.
   Google Scholar
• PAK CYC: Medical management of nephrolithiasis. J. Urol. (1982) 128:1157–1164.
   PubMed Web of Science ®Google Scholar
• DRETLER SP: The physiological approach to the medical management of stone disease. Urol. Clin. N Am. (1998) 25 (Suppl. 4):613–623.
   Google Scholar
• •A recent and thorough review of management.
   Google Scholar
• ETTINGER B, TANY A, CITRON JT et al: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl. J. Merl. (1986) 315:1386–1389.
   PubMed Web of Science ®Google Scholar
• •Randomized study demonstrating efficacy of allopurinol for calcium oxalate stones.
   Google Scholar
• HOFBAUER J, HOBARTH R, SZABO N, MARBERGER M: Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis, a prospective random-ized study. Br. J. Urol. (1994) 73:362–365.
   PubMedGoogle Scholar
• •This study and Abdelhedi's study show no efficacy for citrate therapy.
   Google Scholar
• ABDULHEDI MH, HALL PM, STREEM SB: Can citrate therapy prevent nephrolithiasis? Urology (1993) 91:221–224.
   Google Scholar
• •This study shows no efficacy for citrate therapy.
   Google Scholar
• SAKHASE K, NICOR M, HILL K, PAK CYC: Contrasting effects of potassium citrate and sodium citrate therapies on urinary diminishing and crystallization of stone forming salts. Kidney Int. (1983) 24:348–352.
   PubMed Web of Science ®Google Scholar
• MELNICK I, LANDES RR, HOFFMAN AA, et al: Magnesium therapy for recurring calcium oxalate urinary calculi. Urol. (1971) 17:420–425.
   Google Scholar
• ETTINGER B, CITRON JR, LIVERONE B, DOLMAN LI: Chlorthalidone reduces calcium oxalate calculus recurrence but magnesium hydroxide does not. J. Urol. (1998) B9:679–684.
   Google Scholar
• WILSON DR, STRAUSS AL, MAUEL MA: Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis. Urol. Res. (1984) 12:39–40.
   Google Scholar
• •This study and Cohen's study show little efficacy for magnesium therapy.
   Google Scholar
• COHEN TD, PREMINGER GM: Struvite calculi. Semin. Nephrol. (1996) 16:425–434.
   PubMed Web of Science ®Google Scholar
• •A thorough review of struvite stone disease.
   Google Scholar
• HEIMBACH D, BAUMLER D, SCHOENEICH G, HESSE A: Percutaneous chemolysis. An important tool in the treatment of urolithiasis. Intl. Urol. Nephrol. (1998) 30:655–664.
   PubMedGoogle Scholar
• SHORR E, CARTER AC: Aluminium gels in the manage-ment of renal phosphatic calculi. JAMA (1950) 144:1549–1556.
   PubMed Web of Science ®Google Scholar
• RUTCHIK SD, RESNICK MI: Cystine calculi, diagnosis and management. Urol. Clin. N Am. (1997) 24:163–171.
   PubMed Web of Science ®Google Scholar
• SAKLAHEE K: Pathogenesis and medical management of cystinuria. Semin. Nephrol (1996) 61 (Suppl. 5)435–447.
   Google Scholar